Top news of January: New treatments for sleep apnea, asthma, more
Click Here to Manage Email Alerts
Healio compiled the most-read news in pulmonology posted in January.
Highlights include a possible nasal spray treatment option for patients with obstructive sleep apnea; an FDA clearance for an OSA treatment device; a rise in cannabis-related ED visits from 2005 to 2019 among older adults; an increased risk for cardiovascular disease with mild sleep deprivation; chest X-rays missing 30% of interstitial lung disease cases; and more.
Read these and more top stories in pulmonology below:
Nasal spray treatment may help patients with OSA
A drug administered through a nasal spray may be an alternative treatment option for patients with OSA by improving upper airway collapsibility, according to a study published in CHEST. Read more.
FDA grants 510(k) clearance to OSA treatment device
The FDA has granted 510(k) clearance to a daytime-nighttime appliance, or DNA, to treat patients with mild to moderate OSA, according to a manufacturer-issued press release. Read more.
Cannabis-related ED visits increase among older adults
From 2005 to 2019, the total number of cannabis-related ED visits in California rose from 366 to 12,167 among older adults, according to study results published in Journal of the American Geriatrics Society. Read more.
Even mild sleep deprivation can lead to cardiovascular health risks for women
Healthy women who delayed their normal bedtime by 1.5 hours showed endothelial dysfunction, which increases risk for cardiovascular disease, according to a study published in Annals of the American Thoracic Society. Read more.
Chest X-ray may miss 30% of ILD cases
Compared with high-resolution CT, chest radiography appeared less accurate in detecting ILD, according to a study published in Annals of the American Thoracic Society. Read more.
FDA approves Airsupra, fixed-dose combination rescue asthma inhaler for adults
The FDA approved a pressurized metered-dose inhaler with a fixed-dose combination of albuterol and budesonide for use as rescue medication among patients with asthma aged 18 years and older, according to a manufacturer-issued press release. Read more.
Educational intervention lowers pulse oximeter misuse in ICU
After an educational presentation on the proper use of pulse oximeters, off-label placement of the sensors decreased from 15.2% to 1.6%, according to a study published in Critical Care Nurse. Read more.
Most critical care workers have faced physical, verbal workplace violence
Most critical care workers reported being in a violent situation while at work, which led to decreased workplace satisfaction, according to results of a global survey presented at Society of Critical Care Medicine’s Critical Care Congress. Read more.
Extended VTE anticoagulation reduces major adverse cardiovascular event risk
Patients with venous thromboembolism treated with anticoagulants for more than 3 months had a lower risk for major adverse cardiovascular events, according to a study published in CHEST. Read more.
Longer positive airway pressure use may lower odds for CV events from sleep apnea
The risk for major adverse cardiovascular events among patients with sleep apnea who used positive airway pressure for at least 6 hours a night was lower than among those who used it for less time, according to study results published in American Journal of Respiratory and Critical Care Medicine. Read more.